News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333,404 Results
Type
Article (20099)
Company Profile (130)
Press Release (313175)
Section
Business (105666)
Career Advice (879)
Deals (18555)
Drug Delivery (97)
Drug Development (50873)
Employer Resources (79)
FDA (7707)
Job Trends (7762)
News (186277)
Policy (17360)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (736)
Accelerated approval (1)
Adcomms (17)
Allergies (40)
Alliances (28031)
ALS (53)
Alzheimer's disease (626)
Antibody-drug conjugate (ADC) (86)
Approvals (7720)
Artificial intelligence (131)
Autoimmune disease (11)
Automation (4)
Bankruptcy (177)
Best Places to Work (5569)
BIOSECURE Act (13)
Biosimilars (93)
Biotechnology (58)
Bladder cancer (29)
Brain cancer (18)
Breast cancer (102)
Cancer (996)
Cardiovascular disease (99)
Career advice (711)
Career pathing (20)
CAR-T (54)
Cell therapy (149)
Cervical cancer (5)
Clinical research (42644)
Collaboration (443)
Compensation (146)
Complete response letters (22)
COVID-19 (1100)
CRISPR (21)
C-suite (135)
Cystic fibrosis (56)
Data (1030)
Decentralized trials (2)
Denatured (18)
Depression (24)
Diabetes (133)
Diagnostics (1811)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (72)
Drug pricing (108)
Drug shortages (30)
Duchenne muscular dystrophy (56)
Earnings (38978)
Editorial (29)
Employer branding (10)
Employer resources (73)
Events (48547)
Executive appointments (407)
FDA (8248)
Featured Employer (23)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (297)
Gene editing (45)
Generative AI (17)
Gene therapy (139)
GLP-1 (573)
Government (1836)
Grass and pollen (2)
Guidances (18)
Healthcare (5910)
Huntington's disease (13)
IgA nephropathy (18)
Immunology and inflammation (77)
Indications (17)
Infectious disease (1176)
Inflammatory bowel disease (82)
Inflation Reduction Act (8)
Influenza (22)
Intellectual property (51)
Interviews (116)
IPO (7371)
IRA (45)
Job creations (2438)
Job search strategy (648)
Kidney cancer (7)
Labor market (21)
Layoffs (273)
Leadership (13)
Legal (4125)
Liver cancer (31)
Lung cancer (149)
Lymphoma (83)
Machine learning (2)
Management (30)
Manufacturing (187)
MASH (45)
Medical device (1995)
Medtech (1998)
Mergers & acquisitions (11414)
Metabolic disorders (466)
Multiple sclerosis (45)
NASH (20)
Neurodegenerative disease (44)
Neuropsychiatric disorders (20)
Neuroscience (912)
NextGen: Class of 2025 (2363)
Non-profit (916)
Northern California (1015)
Now hiring (20)
Obesity (293)
Opinion (189)
Ovarian cancer (33)
Pain (63)
Pancreatic cancer (35)
Parkinson's disease (77)
Partnered (10)
Patents (128)
Patient recruitment (46)
Peanut (16)
People (33394)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (13349)
Phase II (18045)
Phase III (14493)
Pipeline (622)
Podcasts (68)
Policy (102)
Postmarket research (1618)
Preclinical (4655)
Press Release (29)
Prostate cancer (57)
Psychedelics (16)
Radiopharmaceuticals (160)
Rare diseases (229)
Real estate (3174)
Recruiting (29)
Regulatory (12489)
Reports (22)
Research institute (817)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (1)
RSV (23)
Schizophrenia (55)
Series A (55)
Series B (31)
Service/supplier (6)
Sickle cell disease (34)
Southern California (974)
Special edition (15)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2010)
State (2)
Stomach cancer (9)
Supply chain (49)
The Weekly (47)
United States (9540)
Vaccines (263)
Venture capitalists (27)
Webinars (11)
Weight loss (233)
Women's health (14)
Worklife (7)
Date
Today (7)
Last 7 days (302)
Last 30 days (1310)
Last 365 days (17052)
2025 (3997)
2024 (17707)
2023 (19671)
2022 (25897)
2021 (26679)
2020 (24919)
2019 (20102)
2018 (15617)
2017 (17303)
2016 (16253)
2015 (18864)
2014 (14854)
2013 (12587)
2012 (13504)
2011 (13833)
2010 (12761)
Location
Africa (409)
Alabama (22)
Alaska (1)
Arizona (63)
Arkansas (8)
Asia (24880)
Australia (3211)
California (2384)
Canada (1057)
China (307)
Colorado (94)
Connecticut (96)
Delaware (66)
Europe (51387)
Florida (408)
Georgia (51)
Idaho (16)
Illinois (233)
India (18)
Indiana (167)
Iowa (3)
Japan (108)
Kansas (60)
Kentucky (17)
Louisiana (1)
Maine (4)
Maryland (354)
Massachusetts (1992)
Michigan (45)
Minnesota (130)
Mississippi (1)
Missouri (26)
Montana (10)
Nebraska (11)
Nevada (17)
New Hampshire (8)
New Jersey (959)
New Mexico (21)
New York (690)
North Carolina (479)
North Dakota (2)
Northern California (1015)
Ohio (80)
Oklahoma (5)
Oregon (21)
Pennsylvania (558)
Puerto Rico (10)
Rhode Island (13)
South America (607)
South Carolina (3)
Southern California (974)
Tennessee (38)
Texas (318)
Utah (53)
Virginia (78)
Washington D.C. (41)
Washington State (204)
Wisconsin (19)
333,404 Results for "pact pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legal
Regeneron Sues Sanofi, Alleging Stonewalling in Dupixent Pact
According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent—including agreements with payers and pharmacy benefit managers that determine pricing and rebates for the drug.
February 7, 2025
·
2 min read
·
Tristan Manalac
Weight loss
Roche Makes Another Obesity Play With Potential $5.3B Amylin Pact With Zealand
Roche and Zealand plan to study petrelintide as a monotherapy and in combination with CT-388, a dual agonist of the GLP-1 and GIP receptors that Roche picked up in its recent acquisition of Carmot Therapeutics.
March 12, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Incyte Backs Out of Immuno-Oncology Pact With Agenus
The partnership dates back to 2015, when Incyte paid $60 million upfront for access to four checkpoint programs, including TIM-3, LAG-3, OX40 and GITR.
February 12, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Takeda Pumps $770M Into Another BridGene Pact to Hit ‘Undruggable’ Targets
BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket agreements with Keros Therapeutics, AC Immune and Degron Therapeutics in the past nine months.
February 25, 2025
·
2 min read
·
Tristan Manalac
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Immunology and inflammation
Gilead Continues Diversification Drive With Potential $1.7B Inflammation Pact With LEO
Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 and IL-13 signaling, which in turn are known inflammatory targets.
January 13, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal
Despite recent enthusiasm around the PD-1/VEGF space, BMO Capital Markets analyst Evan Seigerman noted that Merck’s pact with LaNova Medicines is more “conservativism” on the pharma’s part than confirmatory of recent data in the drug class.
November 14, 2024
·
2 min read
·
Tristan Manalac
Government
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
February 24, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Sangamo’s Stock Plummets as Pfizer Axes Hemophilia Gene Therapy Pact
Sangamo is on course to run out of money within months and has now lost access to up to $220 million in milestone payments from Pfizer.
January 2, 2025
·
2 min read
·
Nick Paul Taylor
C-suite
GSK CEO Emma Walmsley Gets Pay Bump To Align With Pharma Peers
One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 million in 2025.
February 27, 2025
·
2 min read
·
Annalee Armstrong
1 of 33,341
Next
